JP2004503238A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503238A5
JP2004503238A5 JP2002510643A JP2002510643A JP2004503238A5 JP 2004503238 A5 JP2004503238 A5 JP 2004503238A5 JP 2002510643 A JP2002510643 A JP 2002510643A JP 2002510643 A JP2002510643 A JP 2002510643A JP 2004503238 A5 JP2004503238 A5 JP 2004503238A5
Authority
JP
Japan
Prior art keywords
gene product
cell
cancerous
differentially expressed
colon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510643A
Other languages
English (en)
Japanese (ja)
Other versions
JP5363695B2 (ja
JP2004503238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/019313 external-priority patent/WO2001096523A2/en
Publication of JP2004503238A publication Critical patent/JP2004503238A/ja
Publication of JP2004503238A5 publication Critical patent/JP2004503238A5/ja
Application granted granted Critical
Publication of JP5363695B2 publication Critical patent/JP5363695B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510643A 2000-06-15 2001-06-15 結腸癌に関するポリヌクレオチド Expired - Fee Related JP5363695B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21183500P 2000-06-15 2000-06-15
US60/211,835 2000-06-15
PCT/US2001/019313 WO2001096523A2 (en) 2000-06-15 2001-06-15 Polynucleotides related to colon cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011174312A Division JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Publications (3)

Publication Number Publication Date
JP2004503238A JP2004503238A (ja) 2004-02-05
JP2004503238A5 true JP2004503238A5 (enExample) 2008-07-10
JP5363695B2 JP5363695B2 (ja) 2013-12-11

Family

ID=22788525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002510643A Expired - Fee Related JP5363695B2 (ja) 2000-06-15 2001-06-15 結腸癌に関するポリヌクレオチド
JP2011174312A Pending JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011174312A Pending JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Country Status (9)

Country Link
US (1) US20030008284A1 (enExample)
EP (2) EP1953243B1 (enExample)
JP (2) JP5363695B2 (enExample)
AT (1) ATE397094T1 (enExample)
AU (1) AU2001269867A1 (enExample)
DE (1) DE60134275D1 (enExample)
ES (2) ES2305087T3 (enExample)
PT (1) PT1370684E (enExample)
WO (1) WO2001096523A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
EP1575993A4 (en) * 2002-08-26 2007-07-25 Univ Case Western Reserve METHOD FOR TREATING PATIENTS AND IDENTIFYING THERAPEUTICS
GB2409680B (en) * 2002-10-02 2006-09-20 Us Gov Health & Human Serv Methods and medicaments for controlling proliferation of cells
US8222393B2 (en) 2004-06-02 2012-07-17 Tss Biotech Inc. Polypeptide useful for cancer diagnosis and treatment
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
US8435490B2 (en) * 2007-06-21 2013-05-07 The Johns Hopkins University Small peptides specifically bind to colorectal cancers
CA2736170A1 (en) 2007-09-06 2009-03-12 Case Western Reserve University Methods for diagnosing and treating cancers
US8921074B2 (en) * 2008-04-10 2014-12-30 Genenews, Inc. Method and apparatus for determining a probability of colorectal cancer in a subject

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5206152A (en) 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
EP0832980B1 (en) 1989-01-23 2002-06-19 Chiron Corporation Recombinant therapies for infection and hyperproliferative disorders
DK0737750T3 (da) 1989-03-21 2003-09-01 Vical Inc Ekspression af exogene polynucleotidsekvenser i vertebrater
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EP1001032A3 (en) 1989-08-18 2005-02-23 Chiron Corporation Recombinant retroviruses delivering vector constructs to target cells
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
ZA911974B (en) 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
US5252296A (en) 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
US5149655A (en) 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
WO1992002526A1 (en) 1990-07-27 1992-02-20 Chiron Corporation Large comb-type branched polynucleotides
ATE190354T1 (de) 1990-12-20 2000-03-15 Arch Dev Corp The University O Kontrolle der genexpression durch ionisierende strahlung
ATE237694T1 (de) 1991-08-20 2003-05-15 Us Gov Health & Human Serv Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
JPH07503372A (ja) 1992-01-23 1995-04-13 バイカル・インコーポレイテッド 生体外遺伝子導入
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
EP0650370A4 (en) 1992-06-08 1995-11-22 Univ California METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
EP0644946A4 (en) 1992-06-10 1997-03-12 Us Health VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM.
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
EP0673431A1 (en) 1992-12-03 1995-09-27 Genzyme Corporation Gene therapy for cystic fibrosis
AU6818094A (en) 1993-04-22 1994-11-08 Depotech Corporation Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
EP0705344B8 (en) 1993-06-24 2006-05-10 Advec Inc. Adenovirus vectors for gene therapy
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5500356A (en) 1993-08-10 1996-03-19 Life Technologies, Inc. Method of nucleic acid sequence selection
WO1995007994A2 (en) 1993-09-15 1995-03-23 Viagene, Inc. Recombinant alphavirus vectors
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
DE69435223D1 (de) 1993-10-25 2009-09-03 Canji Inc Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
HUT75162A (en) 1993-11-16 1997-04-28 Depotech Corp Vesicles with controlled release of actives
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
DE69535669T2 (de) 1994-05-09 2008-12-04 Oxford Biomedica (Uk) Ltd. Retrovirale vektoren mit verminderter rekombinationsrate
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5474397A (en) 1994-05-31 1995-12-12 Ingersoll-Rand Company Drum access mechanism
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
US5783387A (en) 1995-02-06 1998-07-21 The Regents Of The University Of California Method for identifying and quantifying nucleic acid sequence aberrations
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
EP0832294A1 (en) 1995-06-07 1998-04-01 Pioneer Hi-Bred International, Inc. PCR-BASED cDNA SUBTRACTIVE CLONING METHOD
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5654173A (en) 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5981279A (en) * 1995-11-09 1999-11-09 Allegheny University Of The Health Sciences Compositions and methods to regulate calmodulin gene expression, and uses thereof for influencing cell growth and differentiation
US6045997A (en) 1995-11-23 2000-04-04 Duke University Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
WO1997029212A1 (en) 1996-02-08 1997-08-14 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
DE69739286D1 (de) 1996-05-06 2009-04-16 Oxford Biomedica Ltd Rekombinationsunfähige retrovirale vektoren
EP0941122B1 (en) 1996-08-13 2003-10-29 Chiron Corporation Compositions for polynucleotide delivery
US6007991A (en) * 1997-03-28 1999-12-28 The Research Foundation Of Suny Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer
US6197332B1 (en) 1997-08-13 2001-03-06 Chiron Corporation Lipid-conjugated polyamide compounds and related compositions and methods thereof
US6312922B1 (en) * 1998-02-09 2001-11-06 Genset Complementary DNAs
WO1999038972A2 (en) * 1998-01-28 1999-08-05 Chiron Corporation Human genes and gene expression products ii
AU1726199A (en) * 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor
EP1121437B1 (en) * 1998-10-15 2008-02-20 Novartis Vaccines and Diagnostics, Inc. Metastatic breast and colon cancer regulated genes
JP4652648B2 (ja) 1999-08-27 2011-03-16 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド キメラアンチセンスオリゴヌクレオチド、およびその細胞トランスフェクション処方物

Similar Documents

Publication Publication Date Title
Obama et al. Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma
KR102622307B1 (ko) 후성유전적 염색체 상호작용
CN111742061B (zh) 基于pde4d7表达和术前临床变量的术前风险分层
EP3303616B1 (en) Methods of prostate cancer prognosis
JP2010535473A5 (enExample)
CN101836112A (zh) 用于在人急性白血病中诱导epha7和erk磷酸化的脱调节的方法和组合物
US20080050379A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
JP2010535014A5 (enExample)
CN110062811A (zh) 基于人磷酸二酯酶4d变体7表达的风险评分
JP2005537007A5 (enExample)
CN105765081A (zh) 一种用于预测对采用egfr抑制剂的治疗的响应性的方法
KR20170086469A (ko) Egfr 억제제를 사용한 치료에 대한 반응을 예측하는 방법
KR101346955B1 (ko) 뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
CN105102983A (zh) Ddr2突变作为黑素瘤或基底细胞癌的可靶向的特征
JP5114796B2 (ja) 食道癌の予後診断マーカー遺伝子およびその利用
US20020115057A1 (en) Process for identifying anti-cancer therapeutic agents using cancer gene sets
US20020165180A1 (en) Process for identifying anti-cancer therapeutic agents using cancer gene sets
KR20190086569A (ko) 암 진단에서 후생적 염색체 상호 작용의 적용
CN110452989B (zh) 生物标志物在胃癌检测、诊断中的应用
JP6949315B2 (ja) 肺扁平上皮癌と肺腺癌の鑑別評価方法
JP2004187620A (ja) 腎疾患の疾患マーカーおよびその利用
US20040115625A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
CN107937520B (zh) 与结直肠癌相关的分子标记物、抑制剂、试剂盒和药剂
JP2005525097A5 (enExample)
JP2010501162A5 (enExample)